SGS DIGICOMPLY JOINS THE WORLD’S AI COMMUNITY TO FIGHT COVID-19

 

The US White House and a coalition of leading research groups have prepared a dataset of over 44,000 (and growing) scholarly articles about COVID-19, SARS-CoV-2 and related coronaviruses. There is a need to generate new insights using the advances in natural language processing and other AI techniques due to the difficulty the medical research community has in keeping up with the large and growing volume of research. The group has issued a call to action to provide tools that can help the medical community develop the answers they need to their most important questions on the virus such as:
 
“What is known about transmission, incubation, and environmental stability?” or "What do we know about COVID-19 risk factors?"  or “What do we know about virus genetics, origin, and evolution? or “Help us understand how geography affects virality", etc.
 
SGS Digicomply is responding to this call to action and joining the worldwide AI experts by making available its machine learning technology, data scientists and product team.
 
At its core, the SGS Digicomply system actively monitors the high volume of regulatory and scientific information generated across different industries. All of the various content, regardless of format or language, can be brought into the system in a consistent manner, in English, so actionable insights can be made.  The SGS Digicomply team has responded to this challenge by extending the capabilities to process this new dataset. SGS Digicomply is then being configured to offer a free solution to the medical research community so they can:
  1. - stay up to date on the most pertinent questions impacting their research
  2. - summarize their findings
  3. - share conclusions within the research community

Access the COVID-19 Intel


covid19-v1
Q2 screenshot

A COLLECTION OF RELEVANT ANSWERS

The AI-based system generates relevant Answers to a collection of the most pertinent questions for the medical research community clustered into 9 items: 

  1. What is known about transmission, incubation, and environmental stability?
  2. What do we know about COVID-19 risk factors?
  3. What do we know about virus genetics, origin, and evolution?
  4. What do we know about vaccines and therapeutics?
  5. What do we know about non-pharmaceutical interventions?
  6. What has been published about medical care?
  7. What do we know about diagnostics and surveillance?
  8. What has been published about information sharing and inter-sectoral collaboration?
  9. What has been published about ethical and social science considerations?

EXPLORE DATA AND INSIGHTS

All scientific papers part relevant to Covid-19 Virus, can be explored with different aggregations like: 

  1. Most frequent topics
  2. Articles by source/publication (such as Medrxiv, WHO, Elsevier, Lancet)
  3. Articles by date of publication
  4. Articles by country 
Access the COVID-19 Intel
  1.  
  2.  
image (6)

The Regulatory Intelligence Network

Access the COVID-19 Intel

Terms of use and Privacy policy. Copyright SGS © 2020, Société Générale de Surveillance. All Right Reserved

Back to Top